ArticleActa crystallographica. Section D, Structural biology2023

Novel starting points for fragment-based drug design against mycobacterial thioredoxin reductase identified using crystallographic fragment screening.

Friederike T Füsser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.